Lexeo Therapeutics, Inc. Soared

Mon, Mar 24, 2025 at 07:47 PM

Lexeo Therapeutics, Inc. (LXEO:NASDAQ) shot up at $4.09, representing a gain of 50.9%. On Mon, Mar 24, 2025, LXEO:NASDAQ hit a New 2-Week High of $4.09. The stock appeared on our News Catalysts scanner on Mon, Mar 24, 2025 at 10:29 AM in the 'EARNINGS' category. From Mon, Mar 10, 2025, the stock recorded 80.00% Up Days and 54.55% Green Days

The stock spiked on Wed, Nov 13, 2024 at $11.72 with a volume of 5M+.

About Lexeo Therapeutics, Inc. (LXEO:NASDAQ)

Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases.

Top 10 Gainers:

Sacks Parente Golf Inc. (SPGC:NASDAQ), 2042.86%
MicroAlgo Inc. (MLGO:NASDAQ), 455.16%
Integrated Media Technology Limited (IMTE:NASDAQ), 197.45%
LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 170.49%
VivoPower International PLC (VVPR:NASDAQ), 149.61%
Tungray Technologies Inc (TRSG:NASDAQ), 86.36%
TEN Holdings Inc. (XHLD:NASDAQ), 53.57%
Lexeo Therapeutics, Inc. (LXEO:NASDAQ), 50.92%
Kindly MD Inc. (KDLY:NASDAQ), 44.37%
Above Food Ingredients Inc. (ABVE:NASDAQ), 44.2%